remit is to complement BioPharma activities by tackling both neglected diseases trypanosomiasis , leishmaniasis and malaria and early stage small molecule validation of novel targets mechanisms across a range of potential therapeutics areas .
O O O O B-SKILL O O O O B-SKILL I-SKILL I-SKILL O B-SKILL O B-SKILL O O O B-SKILL I-SKILL I-SKILL I-SKILL I-SKILL I-SKILL I-SKILL O O O O O B-SKILL O O
NN VBZ TO VB NNP NNS IN VBG DT JJ NNS NN , NN CC NN CC JJ NN JJ JJ NN IN JJ NNS VBP IN DT NN IN JJ NNS NNS .